AACR Ambassadors are Running for Research This Fall
When runners cross the starting line at the AACR Rock ‘n’ Roll Philadelphia races later this month, several will...
When runners cross the starting line at the AACR Rock ‘n’ Roll Philadelphia races later this month, several will...
The latest installment of this quarterly series highlights innovative research approaches reported at the AACR Annual Meeting 2024.
Guest Post by Matthew J. Sikora, PhD University of Pittsburgh Cancer Institute
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...
A few important details to help attendees get the most out of their experience at the AACR Annual Meeting...
LGBTQ+ cancer survivors offer lessons learned, and a researcher explains the odds of chronic conditions in LGBTQ+ survivors.
Guest Post by T.J. Sharpe Originally appeared on Philly.com's Patient #1 blog
Guest Post by Peter A. Jones, PhD, DSc Research Director and Chief Scientific Officer Van Andel Research Institute
Racial/ethnic inequities in cancer are well documented. Not only are Black Americans more likely to die of cancer than white Americans, but Black and Hispanic individuals are...
The first paper to be accepted by the AACR’s latest journal, Blood Cancer Discovery, was published online last week....
Funded in partnership with the American Association for Cancer Research (AACR), our new Transatlantic Fellowships provide high-potential early-career researchers...
The AACR is a proud production supporter of the new documentary CANCER: THE EMPEROR OF ALL MALADIES, airing on...
Lymphomas are a collection of blood cancers stemming from aberrant lymphocytes, which are critical components of the immune system....
The 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer is focusing on a...
According to the White House, this was the first time a group this expansive and diverse met under a...
In a study published Tuesday in the American Association for Cancer Research’s journal Clinical Cancer Research, researchers identified two...
Last week, the U.S. Food and Drug Administration (FDA) added a new therapeutic to the armamentarium for oncologists treating...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...
Today, the American Association for Cancer Research (AACR) released its ninth annual Cancer Progress Report. The report highlights how...
For the third year running, the American Association for Cancer Research (AACR) has been selected as the beneficiary of...
Since 1996, the Associate Member Council (AMC) has served as the leadership body for associate members of the American...
Clinical trials are an essential part of cancer research. They ensure that scientific discoveries are translated into advances in...
Conference co-chair Elaine R. Mardis, PhD, discusses the third conference in the AACR's Precision Medicine Series, “Integrating Clinical Genomics...
In less than a month, the AACR Annual Meeting 2018 will kick off in Chicago, Illinois. The meeting is...
Beginning this Friday, Philadelphia will host the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The conference,...
Today is International Day of Women and Girls in Science, a United Nations initiative aimed at encouraging full and...
Every two minutes, a woman somewhere in the world dies of cervical cancer. That harrowing statistic, shared by Anna R....
Head and neck cancers encompass a large group of malignancies that originate in the nasal cavity, sinuses, lips, mouth,...
The FDA has approved nivolumab for treating patients with recurrent or metastatic squamous cell carcinoma of the head...
When Michael Lawing was diagnosed with stage 3 renal cell carcinoma in 1997, he knew almost nothing about the...